< Back to Results
Primary Contact Name
Sidney Clarke
Primary Contact Email Address
clar2358@umn.edu
Primary Contact Phone Number
612-624-0946
Program Name
University of Minnesota Pediatric Blood and Marrow Transplantation & Cellular Therapy Fellowship
Address
2450 Riverside Avenue,
Minneapolis, MN, 55454
Website
https://med.umn.edu/pediatrics/education/fellowships/medical-fellowships/pediatrics-blood-and-marrow-transplant
Program Director/Fellowship Director
Troy Lund
Program Director/Fellowship Director Email
lundx072@umn.edu
Is the primary focus of your program on Blood and Marrow Transplantation (BMT) or Cellular Therapies?
BTH
How long is the Fellowship program at your institution?
One Year
How long is the BMT Fellowship program at your institution?
Not Provided
Option to extend training or research if funding is available?
Yes
Is the primary focus of your program on adult or pediatric populations?
Pediatric
How long before the Fellowship start date should applicants apply?
0-6 Months
When does your Fellowship application period begin?
Select One
When does your Fellowship application period end?
Select One
Interview Format
Flexible
How many training spaces?
One
If you selected other, how many training spaces are there?
Not Provided
When does your program typically start?
July, Flexible
If flexible, please describe
Applications are accepted on a rolling basis & start dates can be negotiated. However, most fellows begin in July.
If you selected yes, please specify the type of visa
J1, H1B
What are the requirements for fellows applying to your program?
Completion of residency training (Board Certified) or equivalent abroad, Completion of Hematology and/or Oncology Fellowship or equivalent (Board Eligible), ECFMG certification if IMG applicant, Eligibility to obtain a State Medical License
If you selected other, please explain
Not Provided
Are there any unique training opportunities in your fellowship program? (For example: rotation with CTRM, H&I Lab, exposure to CAR T Therapy, etc.)
Fellows will serve children from throughout the United States and abroad requiring allogeneic hematopoietic stem cells for high-risk hematopoietic malignancies, primary immune deficiencies, acquired and inherited marrow failures, metabolic disorders, and life-threatening forms of epidermolysis bullosa,
, autologous blood stem cell rescue following high-dose chemotherapy for high-risk solid tumors, cellular therapy for leukemia and solid tumors and gene therapy for a variety of non malignant disease. The fellow will gain expertise in determining patient eligibility, assigning the ideal treatment plan, selecting the most appropriate graft source and managing common peri-and post-transplant complications in both the inpatient and outpatient clinical settings.
,
, In addition, fellows will also have access to:
, -State of the art 24-bed inpatient facility
, -High patient volumes and exposure to novel cell and immune-based therapeutic strategies
, -Close collaboration with an internationally recognized adult BMT center
Continuity Clinic with trainee as primary physician with supervision?
Yes
Approximate volume of cases at your center for the following
Autologous Transplant
10
Approximate Structure (In weeks)
Inpatient
16-17
Outpatient/Consults
16-17
Other (specify)
Not Provided
Sample Schedule Upload
Not Provided
Educational Stipend/Conference funding available:
Yes - Specify
Specify the Educational Stipend/Conference funding available
Historically, BMT fellows have been approximately $2000 for conference travel. Additionally, the fellow receives a $300 Educational Allowance to enhance training.
If you were interested in the standard time frame, what part of the process would you be interested in standardizing?
Not Provided
< Back to Results